Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

IKSUDA THERAPEUTICS LIMITED Active

Scientific & Education


Contact information


Unlock Company Insights Free Access

Get instant access to key company data, decision-maker contacts, and verified insights.

Book a Demo now

Financial statements of IKSUDA THERAPEUTICS LIMITED

According to IKSUDA THERAPEUTICS LIMITED latest financial report submitted on 2025-12-31, the company has a Cash of £1M, Total-Assets of £8M while the Working-Capital is -£6M. Compared with the previous year, the company reported a Cash decrease of -277.56%, which is an equivalent of 3.0 million. At the same time, the Total-Assets went down by -0.95%, or by 73974.


Year:
2024 Not available
2023 Not available
2022 Not available
2021 Not available

Access 20 Years of Financial Data

Book a Demo
  • Reporting period

    12

  • Consolidated A/cs

    N

  • Profit after Tax

    £ -26.1 million

  • Working Capital

    £ -5.8 million

Profit after Tax

IKSUDA THERAPEUTICS LIMITED Business Credit Report

A Business Credit Report for IKSUDA THERAPEUTICS LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for IKSUDA THERAPEUTICS LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

IKSUDA THERAPEUTICS LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

IKSUDA THERAPEUTICS LIMITED Directors and key executives

IKSUDA THERAPEUTICS LIMITED currently employs 37 people. Compared with the previous year, the company has reported a staff increase of 19%, which is an equivalent of 6 employees.
In order to view contact information, including emails and phone numbers for all the employees working at IKSUDA THERAPEUTICS LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

37

119%

1y growth

135%

2y growth

Management Level


18

Top

53

Middle

18

Operational

Employee Job Title Email Phone Country
Adam Lodge Principal Scientist
**********@iksuda.com
+447736****** GB
David Simpson Chief Executive Officer
*************@glythera.com
- GB
Emma Powell Operations Director
***********@glythera.com
- GB
Ian Evetts Chief Business Officer
**********@iksuda.com
- GB
Terrence Kantner Project Manager
*********@glythera.com
- GB

Get direct emails & phone numbers for senior executives working at «IKSUDA THERAPEUTICS LIMITED»

Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.

Install Free Browser Extension

IKSUDA THERAPEUTICS LIMITED Ownership and Group Structure


Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Book a Demo

IKSUDA THERAPEUTICS LIMITED Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 5 people with significant control at IKSUDA THERAPEUTICS LIMITED. One of of major shareholders of IKSUDA THERAPEUTICS LIMITED is CELLTRION, INC., which owns 1311218 SERIES A shares, with a total value of 1,311,218 GBP and MIRAE ASSET CELLTRION NEW GROWTH FUND 1, which owns 724361 SERIES A NON-VOTING shares, with a total value of 724,361 GBP and MIRAE ASSET - CELLTRION NEW GROWTH FUND 1, which owns 721355 SERIES A shares, with a total value of 721,355 GBP and IP2IOP PORTFOLIO (GP) LIMITED - FOR AN ON BEHALF OF IP2IPO, which owns 632777 SERIES A shares, with a total value of 632,777 GBP and IP2IPO LIMITED, which owns 549307 SERIES A shares, with a total value of 549,307 GBP.


Name Quantity Share Type Value
CELLTRION, INC.
1311218 SERIES A 1311218 GBP
MIRAE ASSET CELLTRION NEW GROWTH FUND 1
724361 SERIES A NON-VOTING 724361 GBP
MIRAE ASSET - CELLTRION NEW GROWTH FUND 1
721355 SERIES A 721355 GBP
IP2IOP PORTFOLIO (GP) LIMITED - FOR AN ON BEHALF OF IP2IPO
632777 SERIES A 632777 GBP
IP2IPO LIMITED
549307 SERIES A 549307 GBP

See All Beneficial Owners & Shareholders

Unlock Full Access For Free

IKSUDA THERAPEUTICS LIMITED competitors:

Top 5 similar companies of IKSUDA THERAPEUTICS LIMITED are SILENCE THERAPEUTICS PLC, TIZIANA LIFE SCIENCES LIMITED, NIOX GROUP PLC, CENTESSA PHARMACEUTICALS PLC, SYNAIRGEN LIMITED. View and export all the competitor list of IKSUDA THERAPEUTICS LIMITED by upgrading your account here.


SILENCE THERAPEUTICS PLC


Revenue
423,000.0
Age
32 years
Employees
104
Industry
View Scientific & Education
Website
View https://www.silence******************

TIZIANA LIFE SCIENCES LIMITED


Revenue
-
Age
28 years
Employees
9
Industry
View Scientific & Education
Website
View https://www.tizianalifes**********************

NIOX GROUP PLC


Revenue
48,700,000.0
Age
20 years
Employees
95
Industry
View Scientific & Education
Website
View http://www.*********

CENTESSA PHARMACEUTICALS PLC


Revenue
-
Age
6 years
Employees
114
Industry
View Scientific & Education
Website
View https://www.c************

SYNAIRGEN LIMITED


Revenue
1,234,567.0
Age
22 years
Employees
36
Industry
View Scientific & Education
Website
View http://www.sy************

View & Export IKSUDA THERAPEUTICS LIMITED competitors:

Get the complete list with detailed profiles

Book a Demo

IKSUDA THERAPEUTICS LIMITED news & activities:


EBITDA

The IKSUDA THERAPEUTICS LIMITED-based company said the adjusted EBITDA is now -£24M, compared with the previous year of -44381195.

uk.globaldatabase.com

2025-12-31

Employees

IKSUDA THERAPEUTICS LIMITED number of employees has increased by 19% compared with previous year and now represents a total number of 37.

uk.globaldatabase.com

2025-12-31

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Book a Demo

Frequently Asked Questions regarding IKSUDA THERAPEUTICS LIMITED


Where is IKSUDA THERAPEUTICS LIMITED registered office?

IKSUDA THERAPEUTICS LIMITED is located at The Biosphere Draymans Way Newcastle Helix, United Kingdom.

How can I contact IKSUDA THERAPEUTICS LIMITED?

You can call IKSUDA THERAPEUTICS LIMITED at the following number +441916******

What is the website of IKSUDA THERAPEUTICS LIMITED?

IKSUDA THERAPEUTICS LIMITED website is https://iksuda.co.uk/

How many people work at IKSUDA THERAPEUTICS LIMITED?

According to the latest account statement, there are currently 37 of employees working for IKSUDA THERAPEUTICS LIMITED.

What is IKSUDA THERAPEUTICS LIMITED EBITDA?

For 2025, IKSUDA THERAPEUTICS LIMITED has reported an EBITDA of -£24M, which went up by 85.25% compared to previous year.

What is the Business Credit Score of IKSUDA THERAPEUTICS LIMITED and how reliable is the company?

In order to check the business credit score of IKSUDA THERAPEUTICS LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does IKSUDA THERAPEUTICS LIMITED pay their invoices on time?

By requesting a Business Credit Report for IKSUDA THERAPEUTICS LIMITED, you will be able to gain more insights about the IKSUDA THERAPEUTICS LIMITED payment trends.

Who is the Ultimate Parent of the IKSUDA THERAPEUTICS LIMITED?

Information about the ultimate beneficial ownership IKSUDA THERAPE************* of IKSUDA THERAPEUTICS LIMITED is available when you order a business credit report.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Get Free API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action